Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Cipla

BSE: 500087|NSE: CIPLA|ISIN: INE059A01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 19, 15:22
584.50
0.65 (0.11%)
VOLUME 45,616
LIVE
NSE
Apr 19, 15:22
584.70
0.1 (0.02%)
VOLUME 1,474,785
Announcements on Cipla

17th-Apr-2018 11:23Source: NSE

Cipla Limited

The Exchange has sought clarification from Cipla Limited with respect to recent news item captioned "Cipla gains 4% after USFDA inspection with no data integrity or repeat observations". The Exchange,...

9th-Apr-2018 15:29Source: BSE

Cipla- Board to consider FY18 results & Dividend on May 22, 2018

Cipla Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 22, 2018, inter-alia, to consider and approve audited financial results (standalone an...

9th-Apr-2018 15:22Source: BSE

Cipla- Board Meeting On 22Nd May 2018

Please find attached letter dated 9th April 2018

26th-Mar-2018 18:39Source: BSE

Cipla- Announcement Under Regulation 30 (LODR)

Please find attached letter dated March 26, 2018.

26th-Mar-2018 09:34Source: BSE

Cipla- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Cipla USA announced the launch of an authorized generic version of Aloxi in the United States under applicable agreements with Helsinn Healthcare SA, in response to the at-risk launch by Teva.

26th-Mar-2018 08:44Source: NSE

Cipla Limited

Cipla Limited has informed the Exchange regarding a press release dated March 26, 2018, titled "Cipla Launches Authorized Generic of Aloxi®(Palonosetron HCl Injection 0.25 mg/5 ml)".

20th-Mar-2018 12:13Source: NSE

Cipla Limited

The Exchange has sought clarification from Cipla Limited with respect to recent news item captioned "Cipla shares drop 7% on USFDA observations for Goa unit.". The Exchange, in order to verify the acc...

20th-Mar-2018 12:04Source: BSE

Cipla- Clarifies on news item

With reference to news appeared on www.moneycontrol.com dated March 20, 2018 quoting "Cipla shares drop 7% on USFDA observations for Goa unit", Cipla Ltd has submitted to BSE a copy of Clarification i...

20th-Mar-2018 11:37Source: NSE

Cipla Limited

The Exchange has sought clarification from Cipla Limited with respect to recent news item captioned "Cipla shares drop 7% on USFDA observations for Goa unit.". In this regard, Exchange have advised th...

20th-Mar-2018 10:55Source: BSE

Cipla- Clarification sought from Cipla Ltd

The Exchange has sought clarification from Cipla Ltd on March 20, 2018 with reference to news appeared on www.moneycontrol.com dated March 20, 2018 quoting "Cipla shares drop 7% on USFDA observations ...

1 2 3 4 5 Next >>
Board Meeting (Cipla)

Meeting Date

Remark

2018-05-22

Audited Results & Dividend

Quick Links for Cipla
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.